[artículo] 
inThe British Journal of Psychiatry > Año 2015 - Vol. 206 - No. 5 (Mayo) . - pp. 360-370

Título :	Quetiapine immediate release v. placebo for schizophrenia : systematic review, meta-analysis and reappraisal
Tipo de documento:	texto impreso
Autores:	Paul Hutton, Autor ; Peter J. Taylor, Autor ; Lee D. Mulligan, Autor
Fecha de publicación:	2020
Artículo en la página:	pp. 360-370
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antipsicóticos, Fumarato de quetiapina, Esquizofrenia, Aumento de peso.
Resumen:	Immediate-release (IR) quetiapine has been used to treat schizophrenia since 1997, although all the principal placebo-controlled trials have >50% missing outcome data. New studies with relatively lower rates of participant withdrawal have since been published.
Link:	./index.php?lvl=notice_display&id=22216

[artículo] Quetiapine immediate release v. placebo for schizophrenia : systematic review, meta-analysis and reappraisal [texto impreso] / Paul Hutton, Autor ; Peter J. Taylor, Autor ; Lee D. Mulligan, Autor . - 2020 . - pp. 360-370.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The British Journal of Psychiatry > Año 2015 - Vol. 206 - No. 5 (Mayo) . - pp. 360-370

Palabras clave:	Antipsicóticos, Fumarato de quetiapina, Esquizofrenia, Aumento de peso.
Resumen:	Immediate-release (IR) quetiapine has been used to treat schizophrenia since 1997, although all the principal placebo-controlled trials have >50% missing outcome data. New studies with relatively lower rates of participant withdrawal have since been published.
Link:	./index.php?lvl=notice_display&id=22216